Chair, Science Advisory Board
Theralink Technologies, Inc., Virginia, United States
Dr. Emanuel F Petricoin is a consultant and the Chair of the Science Advisory Board of Theralink Technologies, Inc. and is a co-inventor of the Reverse Phase Protein Array technology used as the Theralink Assay (TM). He is the Co-Director of the Center for Applied Proteomics and Molecular Medicine (CAPMM) at George Mason University since 2005, where he is a University Professor. The focus of the CAPMM is the invention and use of proteomics technologies for personalized therapy, molecular diagnostics and biomarker discovery. Dr. Petricoin’s expertise includes precision medicine, proteomics and protein biomarkers, cell signaling, molecular diagnostic assay development, biologics and cellular therapeutics regulation, as well as artificial intelligence based algorithms. He has co-authored over 475 publications (H-Index 106), and is a co-inventor on over 40 filed and published patents. He has authored over 45 book chapters
Disclosure information not submitted.
Wednesday, February 9, 2022
1:00 PM – 2:30 PM
Wednesday, February 9, 2022
1:30 PM – 2:00 PM